Pro 2013-021 (Jianfeng Group Corporate Bond Listing Announcement)-3
Release time:
2020-08-05
Section III Overview of Bond Issuance
1. Bond Name
Zhejiang Jianfeng Group Co., Ltd. 201 3 Corporate Bonds (Phase I) (hereinafter referred to as "13 Peak 01 " ).
2. Bond Issuance Approval Authority and Document No.
This issue of bonds has been approved by China Securities Regulatory Commission Securities Regulatory License [201 3 ] 595 .
Total 3. Bond Issue
The size of the bond issue is 3 .7 billion yuan.
4. The maturity of this bond variety
The maturity of this corporate bond is 5 years (with 3 end-of-year issuer interest rate increase option and investor resale option).
5. Bond Issuance Method and Issuance Object
(I) Issuance Method
This issue of bonds adopts a combination of online public offering for public investors and offline inquiry agreement placement for institutional investors. Online subscription is concluded in real time according to the principle of "time first" , and offline subscription is conducted in the form of the issuer and the sponsor (lead underwriter) sending a "Placing Payment Notice" to institutional investors or signing an "offline subscription agreement" with them.
(II) Issuing Object
() Online Issuing: Public Investors (except those prohibited by laws and regulations) who hold the securities accounts of A , B , D and F opened by the registration institution.
( 2 ) Offline: Institutional investors who open qualified securities accounts with a registrar (except where purchasers are prohibited by laws and regulations).
6. the lead underwriter and members of the underwriting syndicate
The bonds are underwritten by the sponsor (lead underwriter) Zheshang Securities Co., Ltd. by way of balance underwriting.
The sponsor and lead underwriter of the bonds are Zheshang Securities Co.
7. bond denominationcurrent bond denomination
100 yuan, issued at par value.
8. Bond Annual Interest Rate, Interest Rate and Debt Repayment MethodThe coupon rate of the current bond is
4.90 % , using single interest on an annual basis, excluding compound interest. Interest is paid once a year, the principal is repaid once due, and the last interest is paid with the payment of the principal. The interest payment and principal payment of the bonds shall be handled in accordance with the relevant business rules of the registered company.
The interest date of this bond is2013 6 April 5 , Interest Payment Date is 2006 to 2018 on June 6 5 of each year (in case of legal holidays or rest days postponed to the following 1 working days; No additional interest is charged for each interest payment). If the investor exercises the option of resale, the interest payment date for the resale of some bonds will be May 5 days of each year from 2014 to 2016 (in case of legal holidays or rest days, the interest payment will be postponed to 1 working days of the following ; No additional interest will be charged for each interest payment). The debt registration date for the interest payment of the bonds will be processed in accordance with the relevant regulations of the bond registration agency .
8. Credit Rating Agency and Bond Credit Rating
are comprehensively assessed by Joint Rating
. The credit rating of the current corporate bonds isAA + , and the main credit rating of the issuer is AA . 9. Guarantee
This
Company Bond is provided byTianjin Tianshili Group Co., Ltd. full unconditional and irrevocable joint and several liability guarantee . 10. Bond Trustee
Zheshang Securities Co., Ltd. .
11. Capital Verification of Raised Funds Confirmation
The total amount of bonds issued in this period is RMB 3
.2 billion yuan. The net raised funds after deducting the issuance expenses have been remitted to the bank account designated by the issuer on185 , June# , June 13 , 2013. Tianjian Certified Public Accountants (Special General Partnership) hired by the issuer has issued a capital verification report numbered Tianjian Inspection [2013]181 on the availability of the proceeds of the bonds. 12. Repurchase Transaction Arrangement
With the consent of the Shanghai Stock Exchange, a new pledge-type repurchase transaction can be carried out after the listing of the bonds. The specific conversion rate and other matters shall be implemented in accordance with the relevant regulations of the registered company.Section IV Basic Information on Listing and Custody of Bonds
1. Basic Information on Listing of Current Corporate Bonds
With the consent of Shanghai Stock Exchange, this issue of bonds will be listed on Shanghai Stock Exchange from July 2
, 208 , 2013, 206
,. This issue of bonds is referred to as "13 Peak 01 " , and the securities code is "122227 " . The bonds have been applied to the Shanghai Stock Exchange, and new pledge repurchase transactions can be carried out after listing. The specific conversion rate and other matters shall be implemented in accordance with the relevant regulations of China Securities Depository and Clearing Co., Ltd. 2. the basic situation of corporate bond custody According to the bond custody certificate provided by China Securities Depository and Clearing Co., Ltd. Shanghai Branch.
Section V Main Financial Status of the Issuer
Audit of the Financial Reports of the 1. Issuer in the Last Three Fiscal Years
The Financial Reports of the Company 2010
,2011 and
2012have been audited by Tianjian Certified Public Accountants (Special General Partnership), and issued respectively Tianjian Audit [2011]2058 , Tianjian Audit [2012]2018 and Tianjian Audit [2013]2818 standard unqualified audit reports. II. Financial and Accounting Data for the Last Three Years (I) Brief Consolidated Financial Statements
Brief Consolidated Balance Sheet
Unit: yuan
Project
| 2012 July | 31
2011 July | 31
2010 December July | 31
Total Current Assets |
| 598,184,425.67 |
679,445,334.64 |
583,348,017.58 |
Total Non-current Assets |
| 2,180,185,953.50 |
1,959,405,246.64 |
1,572,530,092.02 |
Assets |
| 2,778,370,379.17 |
2,638,850,581.28 |
2,155,878,109.60 |
current liabilities total |
| 1,013,708,681.11 |
893,010,462.35 |
,733, 298,189.60 |
total non-current liabilities |
| 118,223,645.25 |
189,908,882.59 |
164,905,055.88 |
liabilities total |
| 1,131,932,326.36 |
1,082,919,344.94 |
898,203,245.48 |
Total Shareholders' Equity Attributable to Parent Company |
| 1,514,999,218.55 |
1,420,100,618.20 |
1,157,941,656.48 |
|
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31